The Applicability of Comorbidity Indices in Predicting Chemo toxicity in Non-Small Cell Lung Cancer

被引：1

作者：

Edahyr, Boshra ^{[1
]}

Lind, Michael ^{[2
]}

Karsera, Louise ^{[1
]}

Mafi, Reza ^{[1
]}

Wallace, Karen ^{[1
]}

Howell, Gareth ^{[1
]}

Hemmingway, Carl ^{[1
]}

Stubbs, Karen ^{[1
]}

机构：

[1] Univ Hull, Acad Oncol, Cottingham, England

[2] Univ Hull, Hull York Med Sch, Cottingham, England

来源：

JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期

关键词：

Co-morbidity; toxicity; predictive;

D O I：

10.1016/j.jtho.2016.11.2038

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PUB068

引用

页码：S1487 / S1488

页数：2

共 50 条

[41] Unusual skin toxicity associated with sustained disease response induced by nivolumab in a patient with non-small cell lung cancer [J].

Galli, Giulia ;

Proto, Claudia ;

Cossa, Mara ;

Valeri, Barbara ;

Sdao, Silvana ;

Signorelli, Diego ;

Imbimbo, Martina ;

de Braud, Filippo ;

Garassino, Marina Chiara ;

Lo Russo, Giuseppe .

TUMORI JOURNAL, 2019, 105 (06) :NP57-NP62

[42] Human Immunodeficiency Virus Infection and Non-small Cell Lung Cancer Survival and Toxicity of Antineoplastic Chemotherapy in a Cohort Study [J].

Makinson, Alain ;

Tenon, Jean-Charles ;

Eymard-Duvernay, Sabrina ;

Pujol, Jean-Louis ;

Allavena, Clotilde ;

Cuzin, Lise ;

Poizot-Martin, Isabelle ;

de la Tribonniere, Xavier ;

Cabie, Andre ;

Pugliese, Pascal ;

Reynes, Jacques ;

Le Moing, Vincent .

JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) :1022-1029

[43] Differences In Toxicity Among Platinum-Based Combinations As Reported By Non-Small Cell Lung Cancer (NSCLC) Patients [J].

Kosmidis, P. ;

Deligianni, E. ;

Lagogianni, C. ;

Kosmidis, T. .

JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) :S502-S503

[44] Afatinib with Concurrent Radiotherapy in a Patient with Metastatic Non-Small Cell Lung Cancer [J].

Atmaca, Akin ;

Al-Batran, Salah-Eddin ;

Allgaeuer, Michael ;

Jaeger, Elke .

ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 (05) :262-+

[45] Stereotactic body radiotherapy for stage I non-small cell lung cancer [J].

Martel-Lafay, I. .

ONCOLOGIE, 2012, 14 (05) :282-288

[46] Sex and survival in non-small cell lung cancer: A nationwide cohort study [J].

Radkiewicz, Cecilia ;

Dickman, Paul William ;

Johansson, Anna Louise Viktoria ;

Wagenius, Gunnar ;

Edgren, Gustaf ;

Lambe, Mats .

PLOS ONE, 2019, 14 (06)

[47] Individualized therapy in the adjuvant setting for non-small cell lung cancer (NSCLC) [J].

Celine Mascaux ;

Simon Ekman ;

Christophe Dooms ;

Frances A. Shepherd .

Current Respiratory Care Reports, 2013, 2 (1) :1-9

[48] Prognosis in HIV-infected patients with non-small cell lung cancer [J].

Sigel, K. ;

Crothers, K. ;

Dubrow, R. ;

Krauskopf, K. ;

Jao, J. ;

Sigel, C. ;

Moskowitz, A. ;

Wisnivesky, J. .

BRITISH JOURNAL OF CANCER, 2013, 109 (07) :1974-1980

[49] Safety of current immune checkpoint inhibitors in non-small cell lung cancer [J].

Abdayem, Pamela ;

Planchard, David .

EXPERT OPINION ON DRUG SAFETY, 2021, 20 (06) :651-667

[50] Prognostic and predictive value of MET deregulation in non-small cell lung cancer [J].

Finocchiaro, Giovanna ;

Toschi, Luca ;

Gianoncelli, Letizia ;

Baretti, Marina ;

Santoro, Armando .

ANNALS OF TRANSLATIONAL MEDICINE, 2015, 3 (06)

← 1 2 3 4 5 →